The Quantellect read.As of Nov 19, 2026, 12 active firms cover Bruker Corporation: 6 rate it Buy or better, 5 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets range widely, $35.00 to $80.00 (about 2.3x), a sign of real disagreement on valuation. The average target of $61.00 sits 4% below the current $63.26. The rating mix has stayed broadly stable, with Buy-side ratings easing from 7 to 6 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.43 next quarter toward $2.43 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 active firms
Neutral
Strong Buy00%
Buy650%
Neutral542%
Sell18%
Strong Sell00%
Based on 12 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$61.00
-3.6% downside
Average target across 12 active firms as of Nov 19, 2026 vs $63.26 current
Highest Target$80.00
Average Target$61.00
Lowest Target$35.00
Detailed analyst forecasts for BRKR
Showing 1–15 of 15 named analysts shown · 12 active firms in the rating projection
As of Nov 19, 2026, 6 of 12 active firms rate BRKR a Buy (5 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
BRKR EPS & revenue forecast
EPS · NEXT QUARTER
$0.43
Range $0.33 – $0.54 · 9 analysts · +39% YoY
Next period, 9 analysts expect Bruker Corporation to earn $0.43 a share (range $0.33 – $0.54), versus $0.31 a year earlier. Full-year consensus is $2.13, growing to $2.43 the year after.
REVENUE · NEXT QUARTER
$856.4M
Range $846.2M – $874.0M · 9 analysts · +4% YoY
Revenue is expected to reach $856.4M (range $846.2M – $874.0M), +4.0% year-over-year. Full-year consensus is $3.5B, rising to $3.7B next year.
Top analysts covering Bruker Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BRKR.
#1
Puneet Souda
Leerink Partners · Rank #30
Buy
$85.00+34.4% to target
Overall win rate
57%
+ Follow
#2
Luke Sergott
Barclays · Rank #267
Buy
$70.00+10.7% to target
Overall win rate
43%
+ Follow
#3
Patrick Donnelly
Citigroup · Rank #448
Neutral
$64.00+1.2% to target
Overall win rate
29%
+ Follow
#4
Subbu Nambi
Guggenheim
Buy
$72.00+13.8% to target
Coverage
—
+ Follow
#5
CW
Casey Woodring
JP Morgan
Neutral
$60.00-5.2% to target
Coverage
—
+ Follow
BRKR stock forecast FAQ
What is BRKR's average 12-month price target?+
The 12 active firms with a live target average $61.00 for Bruker Corporation over the next 12 months, ranging from a $80.00 high to a $35.00 low, as of Nov 19, 2026.
Is BRKR stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 12 active firms as of Nov 19, 2026, 6 rate it Buy or Strong Buy, 5 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for BRKR?+
The Street-high target is $80.00 (Leerink Partners), and the Street-low is $35.00 (Goldman Sachs). The average of all 12 active-firm targets is $61.00.
How many active Wall Street firms cover BRKR?+
12 active firms have a recognized rating on Bruker Corporation as of Nov 19, 2026, and 12 active firms carry a live 12-month price target.
Who is the most accurate analyst covering BRKR?+
Among analysts who currently cover BRKR, Puneet Souda of Leerink Partners has the strongest overall Quantellect track record (Rank #30). Their current call is Buy with a $85.00 target.
What is Bruker Corporation's projected EPS for next quarter?+
The consensus estimate is $0.43 per share (range $0.33 – $0.54) across 9 analysts. Full-year EPS is projected at $2.13, rising to $2.43 the following year.
How much revenue is Bruker Corporation expected to report next quarter?+
Consensus revenue is $856.4M (range $846.2M – $874.0M). Full-year revenue is projected at $3.5B, growing to $3.7B next year.
Have analysts been upgrading or downgrading BRKR lately?+
As of Nov 19, 2026, 6 of 12 active firms rate BRKR a Buy (5 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BRKR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.